AVNS.NYSEAvanos Medical, INC

Form 4: Avanos Medical Interim CEO Michael Greiner Acquires Shares and Stock Options

Sentiment:

SEC Form 4

📋All filings for Avanos Medical, INC
🔒Login to Follow

Interim CEO of Avanos Medical, Michael Greiner, reports acquisition of common stock and stock options.

Summary

  • Michael Greiner, Interim CEO of Avanos Medical, filed a Form 4 detailing changes in beneficial ownership.
  • On March 7, 2025, Greiner acquired 34,316 shares of common stock and 73,633 employee stock options.
  • The common stock was acquired at $0 price.
  • Following the transaction, Greiner beneficially owns 224,264 shares of common stock.
  • The employee stock options have an exercise price of $15.24 and expire on March 7, 2035.
  • The stock options vest in three tranches: 30% on March 7, 2026, 30% on March 7, 2027, and 40% on March 7, 2028.
  • The time-based restricted share units (TRSUs) will vest 1/3 on March 7, 2026, 1/3 on March 7, 2027 and 1/3 on March 7, 2028.

Sentiment

Score: 5

Explanation: Neutral sentiment as it is a standard disclosure of insider transactions.

Positives

  • The acquisition of shares and stock options by the Interim CEO could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders.

Stakeholder Impact

  • The transactions could influence investor sentiment regarding the company's leadership and future performance.

Key Dates

DateDescription
03/07/2025Date of transaction: Acquisition of common stock and stock options.
03/07/2026First vesting date for 30% of the stock options and 1/3 of the TRSUs.
03/07/2027Second vesting date for 30% of the stock options and 1/3 of the TRSUs.
03/07/2028Third vesting date for 40% of the stock options and 1/3 of the TRSUs.
03/07/2035Expiration date of the employee stock options.
03/11/2025Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.